Azenta, Inc.

AZTA Healthcare Medical Instruments & Supplies

Azenta, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $593.8 million, up 3.55% from fiscal 2024.

Revenue
+12.0%
EPS
+104.4%
Free cash flow
−134.7%

Quarter to June 2026, against a year earlier

39.13 1.75 +4.68%
Market cap
$1.6B
P/E
0.0×
Fwd P/E
−10.9×
Dividend yield
—
F-score
7/9
Altman Z
3.85
Beneish M
−2.63
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

7 6 5 5
ROE
(3.19%) (3.51%) (10.65%) (7.72%)
ROA
(2.68%) (2.93%) (8.79%) (6.31%)
ROIC
(1.21%) (1.22%) (9.23%) (9.27%)
Return on Tangible Assets
(8.93%) (9.06%) (27.02%) (21.15%)
Average Days of Receivables
93.37 92.11 84.54 88.91
Free Cash Flow per Share
0.84 0.67 0.65 0.22
Free Cash Flow
38.32 30.93 30.05 9.88
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026